Switching the Inhibitor‐Enzyme Recognition Profile via Chimeric Carbonic Anhydrase XII

A key part of the optimization of small molecules in pharmaceutical inhibitor development is to vary the molecular design to enhance complementarity of chemical features of the compound with the positioning of amino acids in the active site of a target enzyme. Typically this involves iterations of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Smirnovienė, Joana, Smirnov, Alexey, Zakšauskas, Audrius, Zubrienė, Asta, Petrauskas, Vytautas, Mickevičiūtė, Aurelija, Michailovienė, Vilma, Čapkauskaitė, Edita, Manakova, Elena, Gražulis, Saulius, Baranauskienė, Lina, Chen, Wen‐Yih, Ladbury, John E., Matulis, Daumantas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095314/
https://www.ncbi.nlm.nih.gov/pubmed/33945229
http://dx.doi.org/10.1002/open.202100042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095314/
https://www.ncbi.nlm.nih.gov/pubmed/33945229
http://dx.doi.org/10.1002/open.202100042

Ejemplares similares